BIDCF yields 3883.50% · JNJ yields 2.14%● Live data
📍 BIDCF pulled ahead of the other in Year 1
Combined, BIDCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BIDCF + JNJ for your $10,000?
BlockchainK2 Corp. engages in investing in blockchain technology solutions for capital markets and other sectors. The company operates a RealBlocks, a platform for fundraising and investing in real estate; Amplify gaming platform, a blockchain-powered service that manages the sales and promotion of video games; and iRecover Coin App to implement the findings and principles of behaviorism, social neurodevelopment, and behavioral economics in a blockchain-based application to support individuals recovering from addiction. It also provides colocation facilities to advanced data processing companies. In addition, the company sells health and beauty products in independent stores, including resorts, spas, pharmacies, salons, hotel chains, and department stores in the United States. The company was formerly known as Africa Hydrocarbons Inc. and changed its name to BlockchainK2 Corp. in May 2018. BlockchainK2 Corp. is based in Vancouver, Canada.
Full BIDCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.